You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 5, May 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Trial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Pediatric Ophthalmology
 •Cardiac Diagnostic Tests
 •Drug Therapy
 •Alert me on articles by topic

Stability of Visual Acuity Improvement Following Discontinuation of Amblyopia Treatment in Children Aged 7 to 12 Years

Pediatric Eye Disease Investigator Group*

Arch Ophthalmol. 2007;125(5):655-659.

Objective  To assess the stability of visual acuity improvement during the first year after cessation of amblyopia treatment other than spectacle wear in children aged 7 to 12 years.

Methods  At the completion of a multicenter randomized trial during which amblyopia treated with patching and atropine improved by at least 2 lines on the electronic Early Treatment of Diabetic Retinopathy Study testing protocol, 80 patients aged 7 to 12 years were followed up while not receiving treatment (other than spectacle wear) for 1 year.

Main Outcome Measure  Ten letters or more (≥2 lines) worsening of visual acuity (measured using the electronic Early Treatment of Diabetic Retinopathy Study testing protocol) during the year following treatment discontinuation.

Results  During the year following cessation of treatment, the cumulative probability of worsening visual acuity (≥2 lines) was 7% (95% confidence interval, 3%-17%); 82% of patients maintained an increase in visual acuity of 10 letters or more compared with their visual acuity before starting treatment.

Conclusion  Visual acuity improvement occurring during amblyopia treatment is sustained in most children aged 7 to 12 years for at least 1 year after discontinuing treatment other than spectacle wear.

Trial Registration  clinicaltrials.gov Identifier: NCT00094692



*Writing Committee: The following members of the Pediatric Eye Disease Investigator Group take authorship responsibility for this study: Lead authors: Richard W. Hertle, MD; Mitchell M. Scheiman, OD; Roy W. Beck, MD, PhD; and Danielle L. Chandler, MSPH. Additional writing committee members (alphabetically): Darron A. Bacal, MD; Eileen Birch, PhD; Raymond H. Chu, OD; Jonathan M. Holmes, BM, BCh; Deborah L. Klimek, MD; Katherine A. Lee, MD, PhD; Michael X. Repka, MD; and David R. Weakley, Jr, MD.
Group Information: A list of the Pediatric Eye Disease Investigator Group members was published in Archives of Ophthalmology. 2005;123:445.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.